EP 1965828 A2 20080910 - PHARMACEUTICAL FORMULATION FOR INCREASED EPITHELIAL PERMEABILITY OF GLUCOSE-REGULATING PEPTIDE
Title (en)
PHARMACEUTICAL FORMULATION FOR INCREASED EPITHELIAL PERMEABILITY OF GLUCOSE-REGULATING PEPTIDE
Title (de)
PHARMAZEUTISCHE FORMULIERUNG ZUR ERHÖHTEN EPITHELIALEN DURCHLÄSSIGKEIT VON PEPTIDEN ZUR GLUCOSE-REGULIERUNG
Title (fr)
FORMULATION PHARMACEUTIQUE POUR LA PERMEABILITE EPITHELIALE ACCRUE DE PEPTIDE DE REGULATION DU GLUCOSE
Publication
Application
Priority
- US 2006061503 W 20061201
- US 29367605 A 20051202
- US 77646406 P 20060224
- US 2006008928 W 20060310
- US 80440606 P 20060609
- US 80454306 P 20060612
- US 80519106 P 20060619
Abstract (en)
[origin: WO2007065156A2] What is described is a pharmaceutical formulation comprising a mixture of a pharmaceutically effective amount of glucose-regulating peptide (GRP) and enhancers, wherein the pharmaceutical formulation is used in the treatment of a metabolic syndrome.
IPC 8 full level
A61K 38/26 (2006.01)
CPC (source: EP)
A61K 9/0043 (2013.01); A61K 38/26 (2013.01); A61P 3/00 (2017.12); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 5/50 (2017.12)
Citation (search report)
See references of WO 2007065156A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007065156 A2 20070607; WO 2007065156 A3 20070719; WO 2007065156 B1 20070913; BR PI0620586 A2 20111116; EP 1965828 A2 20080910; JP 2009518315 A 20090507; MX 2008007075 A 20081112
DOCDB simple family (application)
US 2006061503 W 20061201; BR PI0620586 A 20061201; EP 06846441 A 20061201; JP 2008543590 A 20061201; MX 2008007075 A 20061201